Table 2.
A collection of significantly differentially expressed lncRNAs detected via microarray analysis in seven NPC patients.
| Upregulated | Downregulated | ||
|---|---|---|---|
| lncRNA | log2 fold-change (M/T) | lncRNA | log2 fold-change (M/T) |
| CR620154 | 94.02 | TUBA4B | 1,364.72 |
| LOC84740 | 92.86 | AK128150 | 1,120.20 |
| nc-HOXB9-206 | 87.55 | RP11-79C6.2 | 303.82 |
| RP4-800M22.4 | 67.25 | EFCAB10 | 274.84 |
| RP11-450H5.1 | 65.75 | RP11-1C1.7 | 208.11 |
| RP11-429H5.1 | 64.15 | RP11-275I14.4 | 206.67 |
| CTC-327F10.5 | 62.57 | CR607309 | 197.51 |
| AK096329 | 58.19 | RP1-20N18.4 | 196.02 |
| AC079780.3 | 55.47 | lincRNA-CDHR3 | 195.01 |
| AK129524 | 53.04 | BC041885 | 141.04 |
| AL359062 | 50.10 | lincRNA-TSPAN8 | 137.80 |
| RP11-95M15.1 | 46.94 | BC050410 | 131.80 |
| RP11-455B3.1 | 45.48 | RP4-539M6.14 | 130.89 |
| RP11-188P8.2 | 41.74 | IGKV | 125.27 |
| AC097523.2 | 41.72 | AC013264.2 | 122.93 |
| nc-HOXA11-86 | 41.48 | CES4 | 120.27 |
| RP11-600P1.1 | 38.72 | CLLU1 | 108.35 |
| LOC283392 | 33.97 | TUBBP5 | 108.01 |
| AK096314 | 33.87 | RP11-128M1.1 | 105.58 |
| AC116917.2 | 33.61 | RP4-666F24.3 | 100.17 |
NPC: nasopharyngeal carcinoma; M: metastatic NPC tissue; T: primary NPC tissue.
False discovery rate (FDR) < 0.1%, P < 0.01.